BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 150 filers reported holding BIONTECH SE in Q3 2020. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,628 | +0.7% | 825 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $89,042 | -20.0% | 825 | -7.7% | 0.00% | -50.0% |
| Q1 2023 | $111,366 | -27.2% | 894 | -12.3% | 0.00% | -33.3% |
| Q4 2022 | $153,074 | +11.7% | 1,019 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $137,000 | -11.6% | 1,019 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $155,000 | -53.2% | 1,038 | -46.4% | 0.00% | -40.0% |
| Q1 2022 | $331,000 | -33.8% | 1,938 | 0.0% | 0.01% | -37.5% |
| Q4 2021 | $500,000 | -2.0% | 1,938 | +3.7% | 0.01% | -11.1% |
| Q3 2021 | $510,000 | +9.4% | 1,869 | -10.1% | 0.01% | +12.5% |
| Q2 2021 | $466,000 | -99.9% | 2,080 | -59.1% | 0.01% | +60.0% |
| Q1 2021 | $554,686,000 | +803792.8% | 5,080 | +497.6% | 0.01% | +400.0% |
| Q4 2020 | $69,000 | +590.0% | 850 | +466.7% | 0.00% | – |
| Q3 2020 | $10,000 | +42.9% | 150 | +50.0% | 0.00% | – |
| Q2 2020 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |